Showing results (1001-1010 of 1,566) with videos related to
Sort By:
Pageof 157
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
Association of hormone replacement therapy with increased risk of meningioma in women: A hospital-based multicenter study with propensity score matchingXiaochen Shu, Yun Jiang, Tao Wen, et al.Asia-Pacific Journal of Clinical Oncology|February 12, 2019
Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancerKavita Baghel, Hasan Raza Kazmi, Abhijit Chandra, et al.Asia-Pacific Journal of Clinical Oncology|October 27, 2017
Local recurrence is correlated with decreased overall survival in patients with intermediate high-grade localized primary soft tissue sarcoma of extremity and abdominothoracic wallRuping Zhao, Xiaoli Yu, Yan Feng, et al.Asia-Pacific Journal of Clinical Oncology|October 31, 2017
Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriersAllan 'Ben' Smith, Meera Agar, Geoff Delaney, et al.Asia-Pacific Journal of Clinical Oncology|January 27, 2018
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re-analysis of efficacy and safety data from the ML17032 phase III clinical trialJia Chen, Jianping Xiong, Jiejun Wang, et al.Asia-Pacific Journal of Clinical Oncology|August 26, 2017
Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancerHarminder Takhar, Nimit Singhal, Anna Mislang, et al.Asia-Pacific Journal of Clinical Oncology|August 30, 2017
Phase III randomized trial comparing intravenous to oral iron in patients with cancer-related iron deficiency anemia not on erythropoiesis stimulating agentsVanita Noronha, Amit Joshi, Vijay Maruti Patil, et al.Asia-Pacific Journal of Clinical Oncology|January 16, 2018
MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinomaSima Ardalan Khales, Ehsan Ebrahimi, Eisa Jahanzad, et al.Asia-Pacific Journal of Clinical Oncology|January 17, 2018
Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastomaEugene Wong, Najmun Nahar, Eric Hau, et al.Asia-Pacific Journal of Clinical Oncology|January 20, 2018
Treatment-related toxicities of immune checkpoint inhibitors in advanced cancers: A meta-analysisJohnathan Man, Georgia Ritchie, Matthew Links, et al.Pageof 157